1007 related articles for article (PubMed ID: 26466571)
1. Mutations driving CLL and their evolution in progression and relapse.
Landau DA; Tausch E; Taylor-Weiner AN; Stewart C; Reiter JG; Bahlo J; Kluth S; Bozic I; Lawrence M; Böttcher S; Carter SL; Cibulskis K; Mertens D; Sougnez CL; Rosenberg M; Hess JM; Edelmann J; Kless S; Kneba M; Ritgen M; Fink A; Fischer K; Gabriel S; Lander ES; Nowak MA; Döhner H; Hallek M; Neuberg D; Getz G; Stilgenbauer S; Wu CJ
Nature; 2015 Oct; 526(7574):525-30. PubMed ID: 26466571
[TBL] [Abstract][Full Text] [Related]
2. Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations.
Ljungström V; Cortese D; Young E; Pandzic T; Mansouri L; Plevova K; Ntoufa S; Baliakas P; Clifford R; Sutton LA; Blakemore SJ; Stavroyianni N; Agathangelidis A; Rossi D; Höglund M; Kotaskova J; Juliusson G; Belessi C; Chiorazzi N; Panagiotidis P; Langerak AW; Smedby KE; Oscier D; Gaidano G; Schuh A; Davi F; Pott C; Strefford JC; Trentin L; Pospisilova S; Ghia P; Stamatopoulos K; Sjöblom T; Rosenquist R
Blood; 2016 Feb; 127(8):1007-16. PubMed ID: 26675346
[TBL] [Abstract][Full Text] [Related]
3. Gene mutations in chronic lymphocytic leukemia.
Amin NA; Malek SN
Semin Oncol; 2016 Apr; 43(2):215-21. PubMed ID: 27040699
[TBL] [Abstract][Full Text] [Related]
4. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia.
Ma X; Edmonson M; Yergeau D; Muzny DM; Hampton OA; Rusch M; Song G; Easton J; Harvey RC; Wheeler DA; Ma J; Doddapaneni H; Vadodaria B; Wu G; Nagahawatte P; Carroll WL; Chen IM; Gastier-Foster JM; Relling MV; Smith MA; Devidas M; Guidry Auvil JM; Downing JR; Loh ML; Willman CL; Gerhard DS; Mullighan CG; Hunger SP; Zhang J
Nat Commun; 2015 Mar; 6():6604. PubMed ID: 25790293
[TBL] [Abstract][Full Text] [Related]
5. A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
Amin NA; Seymour E; Saiya-Cork K; Parkin B; Shedden K; Malek SN
Clin Cancer Res; 2016 Sep; 22(17):4525-35. PubMed ID: 27060156
[TBL] [Abstract][Full Text] [Related]
6. Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
Barrio S; Shanafelt TD; Ojha J; Chaffee KG; Secreto C; Kortüm KM; Pathangey S; Van-Dyke DL; Slager SL; Fonseca R; Kay NE; Braggio E
Leukemia; 2017 Jan; 31(1):170-176. PubMed ID: 27469216
[TBL] [Abstract][Full Text] [Related]
7. Deep sequencing identifies genetic heterogeneity and recurrent convergent evolution in chronic lymphocytic leukemia.
Ojha J; Ayres J; Secreto C; Tschumper R; Rabe K; Van Dyke D; Slager S; Shanafelt T; Fonseca R; Kay NE; Braggio E
Blood; 2015 Jan; 125(3):492-8. PubMed ID: 25377784
[TBL] [Abstract][Full Text] [Related]
8. Chronic lymphocytic leukemia: Time to go past genomics?
Roos-Weil D; Nguyen-Khac F; Bernard OA
Am J Hematol; 2016 May; 91(5):518-28. PubMed ID: 26800490
[TBL] [Abstract][Full Text] [Related]
9. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
Fabbri G; Khiabanian H; Holmes AB; Wang J; Messina M; Mullighan CG; Pasqualucci L; Rabadan R; Dalla-Favera R
J Exp Med; 2013 Oct; 210(11):2273-88. PubMed ID: 24127483
[TBL] [Abstract][Full Text] [Related]
10. Growth dynamics in naturally progressing chronic lymphocytic leukaemia.
Gruber M; Bozic I; Leshchiner I; Livitz D; Stevenson K; Rassenti L; Rosebrock D; Taylor-Weiner A; Olive O; Goyetche R; Fernandes SM; Sun J; Stewart C; Wong A; Cibulskis C; Zhang W; Reiter JG; Gerold JM; Gribben JG; Rai KR; Keating MJ; Brown JR; Neuberg D; Kipps TJ; Nowak MA; Getz G; Wu CJ
Nature; 2019 Jun; 570(7762):474-479. PubMed ID: 31142838
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intra-patient clonal and subclonal heterogeneity of chronic lymphocytic leukaemia: evidences from circulating and lymph nodal compartments.
Del Giudice I; Marinelli M; Wang J; Bonina S; Messina M; Chiaretti S; Ilari C; Cafforio L; Raponi S; Mauro FR; Di Maio V; De Propris MS; Nanni M; Ciardullo C; Rossi D; Gaidano G; Guarini A; Rabadan R; Foà R
Br J Haematol; 2016 Feb; 172(3):371-383. PubMed ID: 26597680
[TBL] [Abstract][Full Text] [Related]
12. [The genetic landscape of chronic lymphocytic leukemia].
Marosvári D; Alpár D; Király AP; Rajnai H; Reiniger L; Bödör C
Magy Onkol; 2016 Jun; 60(2):118-25. PubMed ID: 27275638
[TBL] [Abstract][Full Text] [Related]
13. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution.
Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A
Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764
[TBL] [Abstract][Full Text] [Related]
14. B-cell receptor configuration and mutational analysis of patients with chronic lymphocytic leukaemia and trisomy 12 reveal recurrent molecular abnormalities.
Falisi E; Novella E; Visco C; Guercini N; Maura F; Giaretta I; Pomponi F; Nichele I; Finotto S; Montaldi A; Neri A; Rodeghiero F
Hematol Oncol; 2014 Mar; 32(1):22-30. PubMed ID: 23861036
[TBL] [Abstract][Full Text] [Related]
15. A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation.
Lazarian G; Yin S; Ten Hacken E; Sewastianik T; Uduman M; Font-Tello A; Gohil SH; Li S; Kim E; Joyal H; Billington L; Witten E; Zheng M; Huang T; Severgnini M; Lefebvre V; Rassenti LZ; Gutierrez C; Georgopoulos K; Ott CJ; Wang L; Kipps TJ; Burger JA; Livak KJ; Neuberg DS; Baran-Marszak F; Cymbalista F; Carrasco RD; Wu CJ
Cancer Cell; 2021 Mar; 39(3):380-393.e8. PubMed ID: 33689703
[TBL] [Abstract][Full Text] [Related]
16. The complex interplay between cell-intrinsic and cell-extrinsic factors driving the evolution of chronic lymphocytic leukemia.
Sutton LA; Rosenquist R
Semin Cancer Biol; 2015 Oct; 34():22-35. PubMed ID: 25963298
[TBL] [Abstract][Full Text] [Related]
17. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia.
Landau DA; Carter SL; Stojanov P; McKenna A; Stevenson K; Lawrence MS; Sougnez C; Stewart C; Sivachenko A; Wang L; Wan Y; Zhang W; Shukla SA; Vartanov A; Fernandes SM; Saksena G; Cibulskis K; Tesar B; Gabriel S; Hacohen N; Meyerson M; Lander ES; Neuberg D; Brown JR; Getz G; Wu CJ
Cell; 2013 Feb; 152(4):714-26. PubMed ID: 23415222
[TBL] [Abstract][Full Text] [Related]
18. Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.
Edelmann J; Tausch E; Landau DA; Robrecht S; Bahlo J; Fischer K; Fink AM; Bloehdorn J; Holzmann K; Böttcher S; Werner L; Kneba M; Gribben JG; Neuberg DS; Wu CJ; Hallek M; Döhner H; Stilgenbauer S
Leukemia; 2017 Mar; 31(3):734-738. PubMed ID: 27909343
[No Abstract] [Full Text] [Related]
19. An ultra-deep sequencing strategy to detect sub-clonal TP53 mutations in presentation chronic lymphocytic leukaemia cases using multiple polymerases.
Worrillow L; Baskaran P; Care MA; Varghese A; Munir T; Evans PA; O'Connor SJ; Rawstron A; Hazelwood L; Tooze RM; Hillmen P; Newton DJ
Oncogene; 2016 Oct; 35(40):5328-5336. PubMed ID: 27041575
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomic analysis implicates gain of PIK3CA at 3q26 and MYC at 8q24 in chronic lymphocytic leukemia.
Brown JR; Hanna M; Tesar B; Werner L; Pochet N; Asara JM; Wang YE; Dal Cin P; Fernandes SM; Thompson C; Macconaill L; Wu CJ; Van de Peer Y; Correll M; Regev A; Neuberg D; Freedman AS
Clin Cancer Res; 2012 Jul; 18(14):3791-802. PubMed ID: 22623730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
